// App-Quantinova.ai

: Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm Following Treatment for Lymphoma: A Study of the Chronic Malignancies Working Party of the EBMT

Researchers

Presenter

  • Mitja Nabergoj

Principal Investigators

  • Nienke Zinger

  • Uwe Platzbecker

  • Katja Sockel

  • Jurgen Finke

  • Nicolaus Kroger

  • Edouard Forcade

  • Arnon Nagler

  • Arnold Ganser

  • Johanna Tischer

  • Annoek E.C. Broers

  • Jurgen Kuball

  • Keith Wilson

  • Hunault-Berger Mathilde

  • Matthew P. Collin

  • Domenico Russo

  • Estefania Perez Lopez

  • Grzegorz Helbig

  • Alberto Mussetti

  • Kavita Raj

  • Christof Scheid

  • Donal P. McLornan

  • Marie Robin

  • Ibrahim Yakoub-Agha

Medical Centers

  • Northern Centre for Bone Marrow Transplantation, Newcastle Upon Tyne, UK, Newcastle Upon Tyne, United Kingdom

  • Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany

  • University Hospital of Wales, Cardiff, United Kingdom

  • Unit of Blood Diseases and Bone Marrow Transplantation, Department of Clinical and Experimental Sciences, ASST-Spedali Civili, University of Brescia, Brescia, Italy

  • Department of Hematology, UMC Utrecht, Utrecht, Netherlands

  • Haematology Department, Guy's and St Thomas’ NHS Trust, London, United Kingdom

  • Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany

  • Department of Internal Medicine III, University Hospital of Munich, Campus Grosshadern, Munich, Germany

  • Department of Medicine I, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany

  • department of hematology, CHU Angers, Angers, France

  • Department of Hematology, Hospital Duran i Reynals, Instituto Catalán de Oncología, L'Hospitalet De Llobregat, Barcelona, Spain

  • Hopital Saint Louis, APHP, Université de Paris Cité, Paris, FRA

  • Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland

  • Hematology and Bone Marrow Transplant Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel

  • Department of Hematology, Cell Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany

  • Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Hôpital Haut-Leveque, Bordeaux, France

  • EBMT Leiden Study Unit, Leiden, Netherlands

  • Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

  • Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hanover, Germany

  • Hôpital du Valais - Institut Central des Hôpitaux (ICH), Sion, Switzerland

  • Centre Hospitalier Universitaire de Lille LIRIC, INSERM U, Université de Lille, Lille, France

  • Hematology Department, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain

  • University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany

  • University College London Hospitals NHS Trust, London, United Kingdom

  • EBMT Statistical Unit, Leiden, Netherlands

Locations

  • United Kingdom

  • Switzerland

  • Israel

  • Germany

  • France

  • Spain

  • Italy

  • Netherlands

  • United States

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Alpha-thalassemia myelodysplasia syndrome

  • Acute myelocytic leukemia

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Hodgkin's Lymphoma

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved